Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

por Burza, Sakib, Sinha, Prabhat K., Mahajan, Raman, Lima, María Angeles, Mitra, Gaurab, Verma, Neena, Balsegaram, Manica, Das, Pradeep
Publicado 2014

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India

por Burza, Sakib, Sinha, Prabhat K., Mahajan, Raman, Lima, María Angeles, Mitra, Gaurab, Verma, Neena, Balasegarem, Manica, Das, Pradeep
Publicado 2014

Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India

por Burza, Sakib, Sinha, Prabhat Kumar, Mahajan, Raman, Sanz, Marta González, Lima, María Angeles, Mitra, Gaurab, Verma, Neena, Das, Pradeep
Publicado 2014

Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India

por Mahajan, Raman, Das, Pradeep, Isaakidis, Petros, Sunyoto, Temmy, Sagili, Karuna D, Lima, Marıa Angeles, Mitra, Gaurab, Kumar, Deepak, Pandey, Krishna, Van geertruyden, Jean-Pierre, Boelaert, Marleen, Burza, Sakib
Publicado 2015

Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)

por Burza, Sakib, Mahajan, Raman, Sinha, Prabhat K., van Griensven, Johan, Pandey, Krishna, Lima, María Angeles, Sanz, Marta Gonzalez, Sunyoto, Temmy, Kumar, Sunil, Mitra, Gaurab, Kumar, Ranjeet, Verma, Neena, Das, Pradeep
Publicado 2014